C WorldWide Group’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

C WorldWide Group’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,025	Closed	-$547K	–	112
2019 Q1	$547K	Hold	13,025	–	–	0.01%	110
2018 Q4	$541K	Sell	13,025 -6,966	-35%	-$313K	0.01%	113
2018 Q3	$964K	Sell	19,991 -2,901	-13%	-$145K	0.01%	111
2018 Q2	$1.08M	Buy	22,892 +1,061	+5%	+$58.9K	0.02%	109
2018 Q1	$1.34M	Sell	21,831 -3,744	-15%	-$198K	0.02%	92
2017 Q4	$1.38M	Sell	25,575 -2,225	-8%	-$132K	0.02%	97
2017 Q3	$1.87M	Buy	27,800 +21,519	+343%	+$1.23M	0.03%	94
2017 Q2	$340K	Buy	+6,281	New	+$291K	0.01%	116

Other funds holding FSTX

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

C WorldWide Group's FSTX Position: Q2 2019 in Review

C WorldWide Group sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 13,025 shares — an estimated $547K sold.

C WorldWide Group first reported a position in FSTX in Q2 2017 and held it in 8 quarters. The position peaked at $1.87M in Q3 2017. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

C WorldWide Group reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
C WorldWide Group sold 13,025 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $547K.
C WorldWide Group first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2017 and held it in 8 quarters.
C WorldWide Group's F-star Therapeutics, Inc. Common Stock position peaked at $1.87M in Q3 2017.
50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.